United States was Opko Health’s largest region in fiscal 2025, bringing in $436.06M of $606.88M (72%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $597.82M | $546.30M | $436.06M | |||||||||||
| U.S | — | — | — | |||||||||||
| Us | — | — | — | |||||||||||
| Ireland | $141.47M | $48.40M | $51.40M | |||||||||||
| Chile | $68.49M | $65.05M | $62.38M | |||||||||||
| Cl | — | — | — | |||||||||||
| Spain | $23.52M | $24.63M | $26.73M | |||||||||||
| Mexico | $20.22M | $23.87M | $25.52M | |||||||||||
| Mx | — | — | — | |||||||||||
| Israel | $9.74M | $1.77M | $522.00K | |||||||||||
| Other Countries | $2.25M | $3.12M | $4.27M | |||||||||||
| Other | — | — | — | |||||||||||
| Total | $863.50M | $713.14M | $606.88M |
Opko Health brought in $606.88M from its seven regions in fiscal 2025, the year ended December 31, 2025. That was down 14.9% from $713.14M in fiscal 2024. United States was the largest at $436.06M (71.9%), ahead of Chile at $62.38M (10.3%) and Ireland at $51.40M (8.5%). The other four regions brought in $57.04M combined.
Compared with fiscal 2024, Spain grew fastest, up 8.5% to $26.73M, while United States fell the most, down 20.2% to $436.06M. From fiscal 2023 to 2025, combined revenue from these regions fell from $863.50M to $606.88M, a compound annual decline of 16.2%. United States' share of the total rose from 69.2% to 71.9%.
Service was Opko Health’s largest product and service line in fiscal 2025, bringing in $370.28M of $606.90M (61%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Service | $515.28M | $480.67M | $370.28M | ||||||
| Healthcare Insurers | — | — | — | ||||||
| Client Payors | — | — | — | ||||||
| Client Payers | — | — | — | ||||||
| Product | $167.56M | $155.11M | $156.92M | ||||||
| Products | — | — | — | ||||||
| Government Payors | — | — | — | ||||||
| Government Payers | — | — | — | ||||||
| Transfer Of Intellectual Property & Other | $180.70M | $77.40M | $79.70M | ||||||
| Revenue From Transfer Of Intellectual Property & Other | — | — | — | ||||||
| Patients | — | — | — | ||||||
| Total | $863.53M | $713.18M | $606.90M |
Opko Health brought in $606.90M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 14.9% from $713.18M in fiscal 2024. Service was the largest at $370.28M (61.0%), ahead of Product at $156.92M (25.9%) and Transfer Of Intellectual Property & Other at $79.70M (13.1%).
Compared with fiscal 2024, Transfer Of Intellectual Property & Other grew fastest, up 3.0% to $79.70M, while Service fell the most, down 23.0% to $370.28M. From fiscal 2023 to 2025, combined revenue from these lines fell from $863.53M to $606.90M, a compound annual decline of 16.2%. Service's share of the total rose from 59.7% to 61.0%.
Diagnostics was Opko Health’s largest segment in fiscal 2025, bringing in $370.28M of $606.88M (61%).
| Segment | FY 2011 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics | $515.28M | $480.67M | $370.28M | |||||||
| Pharmaceuticals | $348.22M | $232.48M | $236.60M | |||||||
| Pharmaceutical | — | — | — | |||||||
| Total | $863.50M | $713.14M | $606.88M |
Opko Health brought in $606.88M from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 14.9% from $713.14M in fiscal 2024. Diagnostics was the largest at $370.28M (61.0%), ahead of Pharmaceuticals at $236.60M (39.0%).
Compared with fiscal 2024, Pharmaceuticals grew 1.8% to $236.60M, while Diagnostics fell 23.0% to $370.28M. From fiscal 2023 to 2025, combined revenue from these segments fell from $863.50M to $606.88M, a compound annual decline of 16.2%. Diagnostics' share of the total rose from 59.7% to 61.0%.
Opko Health (OPK) reports its revenue by geography, by product and service and by segment. In fiscal 2025, United States was its largest region, bringing in $436.06M (71.9% of the total), followed by Chile at $62.38M (10.3%).
United States was Opko Health's largest region in fiscal 2025, bringing in $436.06M, or 71.9% of the $606.88M total across its seven regions.
Service was Opko Health's largest product and service line in fiscal 2025, bringing in $370.28M, or 61.0% of the $606.90M total across its three product and service lines.
Diagnostics was Opko Health's largest segment in fiscal 2025, bringing in $370.28M, or 61.0% of the $606.88M total across its two segments.
Among Opko Health's regions that make up at least 2% of revenue, Spain grew fastest in fiscal 2025, up 8.5% from $24.63M to $26.73M.
Every figure comes from Opko Health's annual financial filings, as reported. Each line keeps the name Opko Health gives it, and years follow its fiscal calendar.
Opko Health's revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.